IMC Chicago
EW icon

IMC Chicago’s Edwards Lifesciences EW Stock Holding History

IMC Chicago’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,445
Closed -$791K – 6470
2026
Q1 		$756K Buy
+9,445
New +$779K ﹤0.01% 3572
2025
Q3 		– Sell
-24,534
Closed -$1.92M – 3670
2025
Q2 		$1.92M Buy
+24,534
New +$1.83M ﹤0.01% 2038
2024
Q4 		– Sell
-21,606
Closed -$1.51M – 3207
2024
Q3 		$1.43M Buy
+21,606
New +$1.57M ﹤0.01% 1866
2024
Q2 		– Sell
-12,074
Closed -$1.07M – 2666
2024
Q1 		$1.15M Buy
+12,074
New +$1.01M ﹤0.01% 1659

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IMC Chicago's EW Position: Q2 2026 in Review

IMC Chicago sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 9,445 shares — an estimated $791K sold.

IMC Chicago first reported a position in EW in Q1 2024 and held it in 4 quarters. The position peaked at $1.92M in Q2 2025. 888 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • IMC Chicago reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 9,445 Edwards Lifesciences shares in Q2 2026, an estimated $791K.
  • IMC Chicago first reported a position in Edwards Lifesciences in Q1 2024 and held it in 4 quarters.
  • IMC Chicago's Edwards Lifesciences position peaked at $1.92M in Q2 2025.
  • 888 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.